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The ADV-G isolate of Aleutian mink disease parvovirus (ADV) replicates permissively in Crandell feline kidney (CRFK) cells
but is nonpathogenic for mink, whereas the highly pathogenic ADV-Utah isolate is nonviable in CRFK cells. To assign control
of host range in CRFK cells and pathogenicity to specific regions of the ADV genome, we constructed a full-length molecular
clone chimeric between ADV-G and ADV-Utah. If either the map unit (MU) 54–65 (clone G/U-5) or MU 65–88 (clone G/U-7)
sections were ADV-Utah, viability in CRFK cells was abolished, thus indicating that in vitro host range was controlled by two
independent determinants: A in the MU 54–65 segment and B in the MU 65–88 segment. Determinant B could be divided into
two subregions, B1 (MU 65–69) and B2 (MU 73–88), neither of which alone could inhibit replication in CRFK cells, an
observation suggesting that expression of the B determinant required interaction between noncontiguous sequences. Adult
mink of Aleutian genotype inoculated with G/U-8 or G/U-10 developed viremia, antiviral antibody, and histopathological
changes characteristic of progressive Aleutian disease. The capsid sequences of G/U-8 and G/U-10 differed from ADV-G at
five and four amino acid residues, respectively. Our results suggested that the host range and pathogenicity of ADV are
regulated by sequences in the capsid protein gene.
INTRODUCTION
Aleutian mink disease parvovirus (ADV) causes dis-
ease in both adult and newborn mink (Bloom et al., 1994).
Aleutian disease (AD) in adult mink is characteristically a
persistent infection accompanied by a severe disorder of
the immune system. Affected animals have a chronic
viremia, high levels of antiviral antibody, progressive hy-
pergammaglobulinemia, immune complex glomerulone-
phritis, enlargement of lymphoid organs, and massive
infiltration of liver and kidney with lymphocytes and
plasma cells (Bloom et al., 1994; Eklund et al., 1968;
Porter, 1986). Newborn mink, on the other hand, classi-
cally develop a fulminant interstitial pneumonia that re-
sults in death from respiratory distress by 2 weeks of age
(Alexandersen et al., 1987; Alexandersen and Bloom,
1987). However, milder forms of both the adult and new-
born disease (Alexandersen et al., 1994; Bloom et al.,
1994; Hadlow et al., 1983), as well as inapparent infec-
tions (An and Ingram, 1977, 1978), are also described.
Thus there exists a broad spectrum of severity in ADV
infection.
Although host factors, such as age, immune status,
and genotype, play a significant role in determining the
outcome of ADV infection, the variability in disease se-
verity is indisputably regulated by viral determinants
(Bloom et al., 1980, 1994; Oie et al., 1996). Highly virulent
isolates of virus, such as ADV-Utah and ADV-TR, cause
severe disease in adult and newborn mink (Alex-
andersen et al., 1994; Oie et al., 1996) with mortality rates
approaching 100% in both Aleutian and non-Aleutian
genotypes. At the other end of the spectrum from ADV-
Utah and ADV-TR is ADV-G (Alexandersen et al., 1994;
Bloom et al., 1980, 1990). This isolate does not induce AD
in adult mink and has reduced pathogenicity for mink kits
(Alexandersen et al., 1994; Bloom et al., 1980; Oie et al.,
1996). Other isolates of ADV exhibit intermediate patho-
genicity patterns (Hadlow et al., 1983, 1984; Oie et al.,
1996). In addition, ADV-G replicates permissively in Cran-
dell feline kidney cells (CRFK) (Alexandersen et al., 1987),
whereas the pathogenic isolates are replication defec-
tive in the same cells (Alexandersen et al., 1987; Hahn et
al., 1977). Thus there are at least two biological charac-
teristics encoded by the virus: one controls viable repli-
cation in CRFK cells (in vitro host range), and the other
controls the ability to cause disease (pathogenicity).
Mapping of the viral sequence determinants that spec-
ify these characteristics has been greatly facilitated by
the development of full-length molecular clones (Bloom
et al., 1990, 1993, 1994). Full-length constructs of ADV-G
are viable when transfected into CRFK cell cultures,
indicating that the determinant for in vitro host range is
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retained. The rescued virus does not induce antibody,
viremia, or lesions typical of progressive AD, indicating
that the pathogenicity determinant is not present in the
molecularly cloned virus. Attempts to develop full-length
constructs of ADV-Utah from infected mink tissues have
been unsuccessful (Bloom et al., 1988, 1990, 1993), and
we rely on the full-length ADV-G clone as a starting point
for the analysis of sequences from ADV-Utah. When a
large fragment of ADV-Utah [map unit (MU) 15–88], con-
taining the bulk of the nonstructural and capsid proteins,
is substituted into ADV-G, the resulting construct is non-
viable in CRFK cells (Bloom et al., 1993). Thus sequences
regulating the in vitro host range are present in this
portion of the genome, and this construct serves as a
surrogate for ADV-Utah.
In previous efforts to localize more precisely the se-
quence determinants governing pathogenicity and in
vitro host range, we prepared chimeric full-length clones
containing regions of both ADV-G and ADV-Utah (G/U
chimeras) (Bloom et al., 1993). G/U chimeras containing
both large regions of the ADV-Utah nonstructural pro-
teins and several regions of the capsid protein yield virus
when transfected into CRFK cells. However, any con-
struction containing the ADV-Utah MU 54–65 fragment of
the capsid gene does not replicate in vitro. In addition,
substitution of the ADV-G MU 54–65 fragment into a
nonviable G/U chimera restores viability. Thus a deter-
minant of in vitro host range for CRFK cells is present in
the MU 54–65 segment. Furthermore, none of the chi-
meric viruses from our previous study induce anti-ADV
antibody, viremia, or clinical disease, suggesting that the
pathogenicity determinant is not present in any of these
molecular constructs.
In the present work, we constructed additional full-
length chimeric molecular clones to identify portions of
the ADV capsid proteins that regulate CRFK host range
and pathogenicity. Replication of ADV in CRFK cells was
regulated by two independent regions within the capsid
protein gene. In addition, two recombinant viruses that
contained overlapping sections of ADV-Utah VP2 capsid
protein induced viremia, anti-ADV antibody, and patho-
logical changes typical of progressive disease.
RESULTS
In our previous study, we mapped a host range deter-
minant for CRFK replication or viability to the MU 54–65
region of VP2 (denoted A in Fig. 4) (Bloom et al., 1993);
that is, any G/U chimera carrying the A region from
ADV-Utah (e.g., G/U-2, G/U-5) cannot replicate in vitro in
CRFK cells (Fig. 1). However, we were concerned that the
presence of the inhibitory ADV-Utah A region might have
obscured the effect of other capsid sequences on viabil-
ity in CRFK cells or pathogenicity. Consequently, we
prepared additional G/U chimeras (Fig. 1) to define more
precisely the capsid sequences controlling ADV replica-
tion and pathogenicity.
Chimeras G/U-6 and G/U-7 were constructed to ana-
lyze the role of ADV-Utah capsid sequences in the pres-
ence of the viable A region from ADV-G (Fig. 1). Both
G/U-6 and G/U-7 were nonviable, indicating that a se-
quence in ADV-Utah MU 65–88 segment was able to
FIG. 1. Schematic of VP2 capsid sequences contained in chimeric ADV constructs. The VP2 portions of the chimeric ADV molecular clones
described in this study were schematically aligned, indicating the initiation (VP2 ATG, NT 2406, MU 51) and termination (VP2 TAA, NT 4347, MU 92).
The extent of the ADV-Utah sequence (black area) and the MU locations defining the bounds of the various constructs are depicted. The titer in CRFK
cells (FFU/ml) and the pathogenicity for mink of virus stocks rescued from viable plasmids are shown. As noted in the text, G/U-8 also contained the
MU 15–30 portion of ADV-Utah, not contained within the capsid gene region.
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abrogate replication in vitro even in the presence of the
viable A region from ADV-G. This result mapped a deter-
minant, denoted B, to the MU 65–88 region. Conse-
quently, there were two separate determinants contained
within the capsid proteins that independently controlled
CRFK host range or viability: A (MU 54–65) and B (MU
65–88).
Our earlier constructs G/U-9 and G/U-11 contain por-
tions of the ADV-Utah B region yet are viable in CRFK
cells (Fig. 1) (Bloom et al., 1993). This observation sug-
gested that the CRFK host range determinant B might not
be a simple contiguous linear sequence. To examine this
possibility, we made chimeras G/U-8 (ADV-Utah MU 69–
88) and G/U-10 (ADV-Utah MU 73–88) (Fig. 1). Both of
these new clones were also viable in CRFK cells, sug-
gesting that the inhibitory B element could indeed be
divided into two sections, neither of which alone was
sufficient to render a construct nonviable for CRFK cells.
Therefore, it appeared that expression of the inhibitory B
host range determinant required the presence of two
noncontiguous sequences. It was likely that one element
(B1) was present within MU 65–69 and the other (B2) was
present within MU 73–88.
Several additional new clones were also nonviable
(Fig. 1): G/U-1 (the entire ADV-Utah capsid gene), G/U-3
(ADV-Utah capsid from MU 54–88), and G/U-4 (ADV-Utah
capsid from VP2 start to MU 73). These findings con-
firmed previous results that the presence of both the A
and B regions from ADV-Utah in the same construct do
not allow for constitution of a viable virus in CRFK cells.
None of our previous viable clones showed infectivity
in mink (Bloom et al., 1993). We wanted to determine
whether the G/U-8 and G/U-10 were replication compe-
tent in mink. Therefore, Aleutian mink were inoculated
with 105 fluorescence-forming units (FFU) of virus and
tested for the development of anti-ADV antibodies
(Bloom et al., 1975) and viremia (measured by PCR on
serum) (Fig. 2) (Oie et al., 1996). As controls, parallel
groups were mock infected or inoculated with ADV-G or
ADV-Utah. All five mink inoculated with G/U-8 developed
antibody, and the geometric mean titer at 90 days p.i.
was 151. Three of these mink had detectable viremia at
some point, and in two of the five mink, the viremia
persisted. All five mink inoculated with G/U-10 also de-
veloped antibody, but the geometric mean titer at 90 days
p.i. was 12; three of them had transient viremia at 10 days
p.i. The ADV-Utah-infected mink developed persistent
viremia and high titers of anti-ADV antibodies (geometric
mean titer at 90 days p.i. was 256). The mock- and
ADV-G-infected mink developed neither detectable vire-
mia nor antiviral antibody. Thus in contrast to ADV-G and
our earlier chimeric viruses (Bloom et al., 1993), both
G/U-8 and G/U-10 showed clear evidence of in vivo viral
replication and antibody induction.
Another feature of progressive AD is an elevation of
serum g-globulin levels, and the ADV-Utah-infected mink
developed marked increases (32% mean) (Bloom et al.,
1975; Eklund et al., 1968; Porter, 1986). The mean g-glob-
ulin elevation in the five G/U-8 mink was 4.8%, but three
individual values of 10%, 12%, and 11% were noted. The
mean g-globulin elevation in the G/U-10 group was 7.6%,
but one animal developed pronounced hypergamma-
globulinemia (28% increase). The mock and ADV-G
groups had mean elevations of 0.6% and 2.4%, respec-
tively. Thus chimeras G/U-8 and G/U-10 were capable of
FIG. 2. Responses of mink to infection with ADV chimeras. Groups of five Aleutian (Sapphire) mink were inoculated intraperitoneally (0.5 ml) with
PBS (MOCK) (A), 105 FFU of ADV-G (B), 105 FFU of chimeric virus G/U-8 (D), and 105 FFU of chimeric virus G/U-10 (E). As positive control, three mink
were inoculated with 105 50% mink infectious doses of ADV-Utah. (C) At the indicated days after infection (DAYS P.I.), serum samples were collected
and subjected to analysis for anti-ADV antibodies by CEP (E) or viremia by direct serum PCR. Serum samples testing positive by PCR are noted by
filled CEP values (F). All mink were negative by CEP and PCR before inoculation; those points are omitted for simplicity. One of the two G/U-8 mink
viremic at 10 days p.i. became negative by 30 days p.i., and another became persistently viremic at 30 days p.i. A single ADV-Utah mink died between
60 and 90 days p.i.
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inducing g-globulin elevations in some, but not all, in-
fected mink.
Finally, tissues collected from the mink at the time of
death (;120 days p.i.) were examined microscopically
(Fig. 3). The ADV-Utah mink developed classic signs of
severe AD (Eklund et al., 1968; Helmboldt and Jungherr,
1958) (Figs. 3e–h). The livers had collections of lympho-
cytes and plasma cells in the portal areas and in numer-
ous foci within the lobules (Fig. 3e). The kidneys had
massive interstitial infiltrates of lymphocytes and plasma
cells involving both tubules and glomeruli (Fig. 3f). In
addition, hypercellularity, obliteration of capillary loops,
and an obvious increase in the mesangial matrix of the
glomeruli were evident (Fig. 3f). The mesenteric lymph
nodes had moderate hyperplasia and plasmacytosis in
the medullary cords, including Russell bodies (Figs. 3g
and 3h). Mink infected with both G/U-8 (two of five) (Figs.
3i–l) and G/U-10 (three of five) (Figs. 3m–p) also showed
pathological alterations characteristic of typical progres-
sive AD, although they were less widespread than those
seen in the ADV-Utah mink. Neither the glomerular le-
sions nor interstitial infiltrates in the kidneys were as
pronounced (Figs. 3j and 3n). A single animal inoculated
with ADV-G had minimal changes consisting of slight
portal infiltrate and scant interstitial kidney infiltrates (not
shown). Mock-infected animals had none of these
changes (Figs. 3a–d).
DISCUSSION
These experiments have provided important informa-
tion on two aspects of ADV infections. First, we have
shown that viruses rescued from some chimeric molec-
ular clones of ADV can replicate to detectable levels in
vivo and can cause AD. Second, the results have
mapped in more detail the host range determinants of
the ADV genome that govern permissive replication in
vitro.
Two chimeric viruses (G/U-10 and G/U-8) induced vire-
mia and antiviral antibody in adult Aleutian genotype
mink (Fig. 2). Furthermore, several mink inoculated with
these viruses developed progressive disease (Fig. 3)
(Bloom et al., 1994; Eklund et al., 1968). These are the first
molecularly cloned ADV preparations to be frankly patho-
FIG. 3. Histopathological responses of mink infected with ADV chimeras. Photomicrographs of representative areas of liver (203), kidney (203),
and mesenteric lymph node (103 and 203) from mock infected mink (a–d) and from mink infected with ADV-Utah (e–h), chimeric ADV G/U-8 (i–l), or
chimeric ADV G/U-10 (m–p) are shown.
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genic for mink, and it will now be possible to study viral
pathogenesis with a molecularly derived virus of pre-
cisely defined sequence. Previous pathogenesis studies
have used virus prepared from infected animals, and in
vivo derived virus is coated with antiviral antibody
(Chesebro et al., 1975; Porter and Larsen, 1967). Antibody
enhances ADV infection of phagocytic target cells and
restricts both in vivo and in vitro infection (Alexandersen
et al., 1988; Bloom et al., 1994; Dworak et al., 1997; Kanno
et al., 1993). Furthermore, the use of antibody-coated
virus might mask other primary target cells, such as type
2 alveolar cells in which the virus replicates permissively
in the absence of antibody (Alexandersen et al., 1987,
1994). Thus the use of in vivo derived ADV may have
altered the initial virus–animal host interactions, and
these concerns will be obviated by using pathogenic
chimeric viruses.
The pathogenic molecular constructs G/U-8 and
G/U-10 were based on ADV-G but contained VP2 capsid
sequences from ADV-Utah. In previous studies, we ex-
amined the VP2 sequences from a number of in vivo
pathogenic isolates of ADV (Bloom et al., 1988;
Gottschalk et al., 1991; Oie et al., 1996). To identify amino
acid residues that might be unique to pathogenic ADV
isolates, we aligned the VP2 sequences of G/U-8 and
G/U-10 with ADV-G, ADV-Utah, and three other in vivo
pathogenic isolates: ADV-TR, ADV-Pullman, and the Dan-
ish ADV-ZK8 (Fig. 4) (Bloom et al., 1988; Gottschalk et al.,
1991; Oie et al., 1996). Only two residues (Q at VP2
position 395 and D at VP2 position 534) were unique to
all the pathogenic viruses, including G/U-8 and G/U-10.
In addition, G/U-10 had an isoleucine residue (I) at posi-
tion 352, whereas G/U-8 and the in vivo isolates had
valine (V). There are two other positions, 434 and 491, at
which most of the in vivo isolates vary from ADV-G (Oie
et al., 1996). If some or all of these variant residues were
responsible for conferring pathogenicity, the effect must
be mediated by a very few amino acids. Finally, G/U-8
and G/U-10 were not as uniformly or as severely patho-
genic as ADV-Utah, a variability noted with some in vivo
isolates of ADV (Hadlow et al., 1983; Oie et al., 1996).
Site-directed mutagenesis studies, which are under way,
will enable us to examine the role of the specific capsid
residues and determine whether pathogenicity can be
increased by selective changes.
Two regions of VP2 independently regulated the ability
of full-length molecular clones to replicate in CRFK cells
(Fig. 4). Determinant A is located within the MU 54–65
segment of VP2, a section in which there are only three
amino acids that consistently differ between ADV-G and
viruses that are nonviable for CRFK (Oie et al., 1996). The
second determinant, B, is more complex, and its expres-
sion required cooperative interactions between the two
subregions B1 and B2. The most likely explanation is that
there are tertiary interactions between nonadjacent
amino acids in B1 and B2. Determinant B1 contains the
hypervariable region of VP2. However, because both
sequence types of this region (T. . .T.DAV and Q. . .E.TGT)
(Fig. 4) (Bloom et al., 1988, 1993; Oie et al., 1996) can
exist in CRFK-viable constructs, the residues in B1 that
interact with B2 to control host range may not be the
hypervariable ones. The B2 segment also contains a
limited number of amino acids divergent between patho-
genic and nonpathogenic constructions (Fig. 4). In addi-
FIG. 4. Mapping of ADV pathogenicity and CRFK host range determinants of VP2. The locations of the CRFK host range determinants A, B, B1, and
B2 are depicted under a schematic map of VP2. The scale shows the map unit (MU) extent of the 647-amino-acid VP2 from the start at MU 51 to the
termination at MU 92. In addition, the ADV-Utah segments contained within the VP2 sequences of the pathogenic ADV chimeras, G/U-8 and G/U-10,
are shown. The position of conserved differences in A and B and the particular variant amino acids in ADV-G, chimera G/U-8, chimera G/U-10, and
the pathogenic in vivo isolates ADV-Utah, ADV-TR, ADV-Pullman, and ADV-ZK8 are indicated. Differences falling outside of the CRFK host range
determinants A and B are not shown.
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tion, the ADV-Utah B2 was contained in the two patho-
genic molecular clones: G/U-8 and G/U-10 (Fig. 4). Stud-
ies in progress will attempt to determine whether the
same residues regulate host range and pathogenicity.
These experiments will be enhanced by structural stud-
ies to localize specific residues within the virion struc-
ture (Agbandje et al., 1995).
The mechanism by which capsid sequences might
regulate ADV host range for CRFK is obscure, but the fact
that intact capsid proteins are detected after primary
transfection with nonviable plasmids indicates that the
block is not simply failed synthesis (Bloom et al., 1993).
Perhaps the capsid proteins of the nonviable plasmids
are incapable of assembling into particles, a hypothesis
that is testable using expression in recombinant baculo-
viruses (Christensen et al., 1993; Wu et al., 1994). Alter-
natively, the defect might be in capsid protein transport,
receptor recognition, or genome encapsidation functions
(Ball-Goodrich and Tattersall, 1992; Previsani et al., 1997;
Strassheim et al., 1994; Truyen and Parrish, 1992). In
addition, it is conceivable that virus might be produced
after the initial round of transfection but be incapable of
initiating subsequent rounds of infection (Gardiner and
Tattersall, 1988; Tattersall and Bratton, 1983).
Capsid proteins of a variety of nonenveloped viruses,
including parvoviruses, influence tropism, host range,
and pathogenicity by diverse mechanisms. In the MVM
and the CPV/FPV systems, the determinants for host
range and tropism are encoded within VP2 and map to
the surface of the capsid (Ball-Goodrich and Tattersall,
1992; Chang et al., 1992; Gardiner and Tattersall, 1988;
Parker and Parrish, 1998; Strassheim et al., 1994; Truyen
and Parrish, 1992); however, the effect is exerted at an
intracellular step after cell entry, before viral DNA ampli-
fication (Ball-Goodrich and Tattersall, 1992; Previsani et
al., 1997). Furthermore, in the case of CPV/FPV, the in
vivo and in vitro host range determinants are distinct, yet
both are controlled by the capsid proteins. In the TMEV
system (Lipton and Jelachich, 1997), it appears that a
specific conformation of VP1 and VP2 influences persis-
tence and pathogenicity by modulating virion binding to
host cells. In the poliovirus system, the effect of capsid
gene residues on host range and neuropathogenicity is
complex (Colston and Racaniello, 1995; Couderc et al.,
1996), but it seems to involve modulation of receptor
binding, changes in capsid conformation after binding, or
both (Colston and Racaniello, 1995; Couderc et al., 1996;
Murray et al., 1998). A single amino acid in the VP1
capsid protein of coxsackievirus B4 influences how effi-
ciently B and T cells are recruited to the pancreas of
infected mice and consequently how much pancreatic
destruction occurs (Ramsigh et al., 1997). Finally, mutant
residues in polyomavirus VP1 appear to enhance virus
spread and pathogenicity by altering the surface confor-
mation of the virion and lowering the affinity of the virus
for its receptor (Bauer et al., 1995; Dubensky et al., 1991;
Freund et al., 1991). Thus it is clear that there a number
of potential avenues by which capsid proteins can influ-
ence the outcome of virus infection in vitro and in vivo.
We intend to scrutinize ADV infections more precisely
and elucidate which, if any, of these mechanisms are
operational.
Our data suggest that G/U-8 was more pathogenic
than G/U-10, although neither was as virulent as ADV-
Utah (Fig. 2). This might have resulted from coding dif-
ferences in the capsid sequence, and the VP2 gene of
G/U-8 contains an additional ADV-Utah residue (valine
352) not present in the G/U-10. However, G/U-8 also
contains a short segment of the ADV-Utah left open
reading frame that codes for NS1 (Bloom et al., 1988).
Although large portions of the ADV-Utah left open read-
ing frame do not confer pathogenicity on constructs with
ADV-G capsid regions, they might act in concert with
ADV-Utah capsid sequences to accentuate pathogenicity
or in vivo replication. The three amino acid differences
between ADV-G and ADV-Utah in this NS1 section (MU
15–30) (Bloom et al., 1988; Gottschalk et al., 1994) do not
reside in a well-characterized domain of the NS1 protein
(Christensen et al., 1997; Legendre and Rommelaere,
1992; Skiadopoulos et al., 1992; Vanacker and Rom-
melaere, 1995). However, uncharacterized noncoding se-
quences in this section affect both the constitutive and
the trans-activated activity of the ADV P36 capsid protein
promoter (Storgaard et al., 1993). Although no experi-
ments have compared the ADV-G and ADV-Utah promot-
ers, differences between G/U-8 and G/U-10 may be a
consequence of relative promoter function. In this re-
gard, there is precedent for determinants of parvoviral
host range residing in the nonstructural region (Brown-
stein et al., 1992; Naeger et al., 1990; Vasudevacharya
and Compans, 1992). Construction of additional chime-
ras and comparisons of the ADV-G and ADV-Utah pro-
moters will be required to examine this possibility.
In summary, molecular clones of ADV were generated
that both replicated in cell culture and caused AD in
adult mink. Pathogenicity as well as in vitro replication
competence appeared to be related to short sequences
in the capsid protein gene. These new constructions will
provide useful tools both in the fine mapping of viral




The molecularly cloned ADV-G (XXI-Q-3–15) and other
replication competent chimeric viruses were propagated
and assayed in CRFK as described previously (Bloom et
al., 1990, 1993). In vivo propagation and assay of ADV-
Utah in adult Aleutian genotype (Sapphire) or mink kits
have also been described (Oie et al., 1996).
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Molecular cloning techniques
Standard techniques were used for molecular cloning,
DNA sequencing, restriction enzyme digestion, agarose
gel electrophoresis and plasmid preparation (Bloom et
al., 1988, 1990; Oie et al., 1996). Full-length molecular
clones were transformed into and amplified in Esche-
richia coli JC8111 (recBCsbcrecF) (Bloom et al., 1990;
Boissy and Astell, 1985). Other plasmids were main-
tained in E. coli JM109 (Yanisch-Perron et al., 1985). The
structures and the successful maintenance of the unsta-
ble right-hand (MU 100) hairpin were confirmed by re-
striction enzyme analysis.
Chimeric molecular clones (denoted G/U) were con-
structed by substitution of ADV-Utah fragments into the
ADV-G molecular clone (formerly denoted as XXI-Q-3–15)
(Bloom et al., 1990, 1993). Individual constructs and the
segments that were ADV-Utah were G/U-1 (MU 7–94),
G/U-2 (MU 15–88, formerly denoted as XX-B-1; Bloom et
al., 1993), G/U-3 (MU 54–88), G/U-4 (MU 15–73), G/U-5
(MU 54–65, formerly denoted as XXII-K-1; Bloom et al.,
1993), G/U-6 (MU 15–54 and MU 65–88), G/U-7 (MU
65–88), G/U-8 (MU 15–30 and 69–88), G/U-9 (MU 65–73,
formerly denoted as XVII-T-2–2; Bloom et al., 1993),
G/U-10 (MU 73–88), and G/U-11 (MU 30–54 and MU
65–69).
Plasmids for transfection were batch prepared using
commercially available kits from Promega (Madison, WI)
and stored in aliquots as ethanol precipitates. Immedi-
ately before use, the DNA was collected by centrifuga-
tion and resuspended in sterile deionized water, and the
concentration was verified by agarose gel electrophore-
sis (Bloom et al., 1990, 1993).
Individual 35-mm culture dishes of CRFK cells were
transfected with 5 mg of purified plasmid DNA and incu-
bated for 5 days at 31.8°C (Bloom et al., 1990, 1993). Cell
pellets were collected in 1 ml of medium, freeze-thawed,
sonicated, and blindly passaged five times in cultures of
CRFK before assay (Bloom et al., 1993). To assess the
ability of the recombinant plasmids to induce viral anti-
gens, transfections with 1 mg of plasmid were performed
in four-well Labtek chambers (Bloom et al., 1993). At the
time of harvest, the specimens were fixed in acetone and
stained for ADV antigens as described. As in previous
work (Bloom et al., 1993), all recombinant ADV plasmids,
whether ultimately viable or not in CRFK cells, induced
ADV antigens after primary transfection.
In vivo infectivity and pathogenicity
Adult Sapphire (Aleutian genotype) mink (Mustela vi-
son) from an ADV-negative farm were housed in sheds in
modified primate cages as reported previously (Oie et al.,
1996). All work involving animals was performed under
supervision of the Rocky Mountain Laboratories Animal
Care and Use Committee, and experimental manipula-
tions were carried out under ketamine–acepromazine
anesthesia.
After the collection of a preinoculation serum sample,
groups of mink were inoculated intraperitoneally with 0.5
ml containing 105 FFU of ADV-G (Bloom et al., 1980) and
viable chimeric viruses or 105 50% mink infectious doses
of ADV-Utah (Bloom et al., 1985; Oie et al., 1996). Control
mink were inoculated with 0.5 ml of diluent. Animals
were bled immediately before infection and at 10, 30, 60,
and 90 days after inoculation. Serum samples were ob-
tained by jugular venipuncture into Vacutainer Plus plas-
tic centrifuge tubes containing SST gel and Clot Activator
(Becton-Dickinson). Mink infected with the highly patho-
genic ADV-Utah were maintained in a separate shed.
Serological response to ADV infection was assessed
by counterimmune electrophoresis (Bloom et al., 1975,
1997) and determination of the percent serum g-globulin
level by serum protein electrophoresis (Bloom et al.,
1975, 1994; Eklund et al., 1968) using a horizontal thin-
layer agarose gel system (Ciba-Corning). The increase in
the percent g-globulin between the prebleeding and 90
days p.i. bleeding samples was determined using laser
densitometry.
The presence of viremia was determined by perform-
ing a PCR assay on heat-treated serum (Bloom et al.,
1997; Oie et al., 1996). This method, amplifying a 692-bp
fragment (MU 54.47–68.49, ADV-G nucleotides
2587–3279), can detect ,1 fg (,10 genomes) in 2.5 ml,
the equivalent of ,4000 genomes per milliliter of serum
(Oie et al., 1996). The use of PCR to detect viremia is
;100-fold more sensitive than the dot-blot method used
previously (Bloom et al., 1987). Controls and precautions
used for this technique have been reported in detail
(Bloom et al., 1997; Oie et al., 1996).
Paraffin sections from blocks of liver, spleen, kidney,
and mesenteric lymph node, collected at necropsy, were
prepared and stained with hematoxylin–eosin according
to standard histological procedures. Specimens were
blindly evaluated for the presence of microscopic lesions
characteristic of progressive AD (Eklund et al., 1968;
Hadlow, 1994; Helmboldt and Jungherr, 1958).
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